Skip to content

The application of ultrasound-guided IPACK block under the positioning of the distal femoral intercondylar fossa in the multimodal analgesia of total knee arthroplasty

Application of ultrasound-guided IPACK block in intercondylar fossa positioning in multimodal analgesia of total knee arthroplasty

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100046621
Enrollment
Unknown
Registered
2021-05-23
Start date
2021-05-24
Completion date
Unknown
Last updated
2022-01-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gonitis

Interventions

experimental group:Ultrasound-guided IPAK block with intercondylar fossa localization

Sponsors

Subei People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 65 to 85 years; 2. The ASA classification is I and II; 3. Perform total knee replacement surgery; 4. The subjects (or their legal representatives) have signed an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Have a history of myocardial infarction or unstable angina pectoris within 6 months before screening, or have a history of serious arrhythmia such as degree II and above atrioventricular block, or a history of NYHA cardiac function classification II and above; 2. Past mental system diseases (such as schizophrenia, depression, etc.) and cognitive dysfunction, or history of epilepsy, Parkinson's syndrome; 3. Subjects who have not received regular antihypertensive treatment or have poor blood pressure control (systolic blood pressure >=160mmHg or =100mmHg or = 11.1mmol/L; 5. Abnormal coagulation function during the screening period: prothrombin time (PT) is prolonged beyond the upper limit of normal by 3 seconds and/or activated partial thromboplastin time (APTT) is prolonged beyond the upper limit of normal by 10 seconds; 6. Taking opioid analgesics continuously for more than 10 days, or the time of taking the last drug is shorter than the 5 half-life of the drug at random.

Design outcomes

Primary

MeasureTime frame
a numerical rating scale (NRS) score;Serum C-reactive protein (CRP) and interleukin-6 (IL-6);Bromage score;Quadriceps muscle strength grading;Walking distance;

Secondary

MeasureTime frame
Cumulative use of remedial analgesics;Total number of PCA pump compressions;

Countries

China

Contacts

Public ContactWang Cunjin

Subei People's Hospital

zebra1987@126.com+86 18051061453

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026